Presenter Information

Home / Presenter Information

Abstract submission for the CMV-PHP is now closed. Notifications of acceptance will go out on or around May 15, 2025.
A full schedule of the conference will be posted by the end of May.

Abstracts for the CMV Conference may be considered for an instructional session, breakout presentation* or a poster session. As part of your submission, you will indicate your preference for presentation format.

  • Instructional sessions will be offered on Sunday afternoon, September 7, 2025. Instructional Sessions are for sessions/topics that do not fit into the standard breakout session format, such as topics requiring more than the standard 30 minutes offered for breakout sessions or require a more interactive or hands-on experience than can be adequately achieved in the standard 30 minutes offered for breakout sessions.

  • Breakout sessions are 30 minutes in length. There will be four concurrent sessions during the breakout portions of the conference.

  • NEW THIS YEAR: We will offer TWO 8-minute RAPID FIRE presentation options. One Rapid Fire option will be specifically for students and/or new researchers. Rapid fire presentations will have all conference attendees in one room hearing several fast-paced sessions given in succession. Q&A will follow the final session given. Rapid fire presenters are also asked to create a poster to be discussed during a Poster Presentation time. The poster provides an opportunity to further detail your research and gives attendees additional time to ask questions.

*If you choose "presentation only" and your abstract is not chosen for presentation, the planning committee may request you present a poster. However, you can choose to decline this request.

Presentation Tracks

Abstracts for presentations may be submitted in one of the tracks indicated below. The lists of potential topics are ideas only and not meant to be limiting.

  1. Research to Practice (e.g., epidemiology, newborn screening, maternal/infant diagnosis, drug treatment and prevention clinical trials, immunopathogenesis, molecular virology)
  2. Public Health Implications (e.g., policy implementation, community and clinical prevention measures, community engagement, behavioral prevention trials, awareness and prevention messaging studies, surveillance)
  3. Policy (collaboration to develop or influence evidence-based policies for CMV testing and education in a variety of settings)
  4. Early Intervention (e.g., intervention measures for symptomatic vs. asymptomatic at birth, assistive technologies, audiology services, benefits of establishing a medical home, physical therapy, vision services, speech and language therapy)
  5. Family Support (e.g., family counseling and trainings, navigating insurance, state and local resources, parent-to-parent support groups)

Abstracts that are considered to be a commercial product endorsement in the opinion of the conference planning committee will not be accepted. All abstracts must be in English. Presenters must register for the CMV Public Health and Policy Conference.

Abstract Review and Scoring

The CMV Public Health and Policy Conference strives to provide key stakeholders an opportunity to identify areas of concern, promote collaboration, and share best practices. Conference participants range from state and local programs to the federal level and from physicians to families. The goal of the CMV conference is to raise awareness, delineate prevention efforts, provide information about early intervention options, and disseminate family support resources in an effort to reduce the number of babies born with CMV and connect families affected by CMV with the resources they need to improve their quality of life.

Abstract submissions will be reviewed and scored according to the following criteria by individuals appointed by the conference planning committee.

  1. Relevance and significance to the prevention, diagnosis, treatment, early intervention, and family support services for infants and young children with CMV and their families. [1 - 20 points]
    • The abstract should address a current topic and information appropriate for the purposes of the conference goal.
    • The abstract should address important issues or gaps related to improving CMV-related services.
    • The abstract should inform, enable, or update others in improving CMV-related services regarding potential issues related to clinical practice, education of professionals/families, or future research.
    • The abstract should have the potential to advance the practice/knowledge base of CMV.
    • The abstract should expand the discussion or perspective to build on existing knowledge or address new knowledge, discoveries, methodologies, tools, technologies, or practices.
  2. Overall clarity [1 - 10 points]
    • The abstract should be well written and organized in a coherent manner.
    • The amount of information to be presented should be appropriate for the proposed session length and format.
    • The abstract should clearly describe the presentation's goals and learner outcomes.
    • The abstract should provide prospective participants enough information to determine if the session will meet their needs.
    • If research results are included, they should be clearly described and supported by statistical findings with the conclusions supported by the results.

Copyright © 2014-2025 Utah State University. All Rights Reserved.